Phibro Animal Health (PAHC) Projected to Post Earnings on Wednesday

Key Points

• Phibro Animal Health Corporation is set to report its Q4 2025 earnings on August 27, 2025, with an expected earnings of $0.52 per share and revenue of $362.24 million.
• The company announced a quarterly dividend of $0.12, which will be paid on September 24, 2025, representing a 1.5% dividend yield.
• Significant interest from institutional investors is noted, with 99.34% of the stock currently owned by them, reflecting strong investor confidence.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) will likely be announcing its Q4 2025 results after the market closes on Wednesday, August 27th. Analysts expect the company to announce earnings of $0.52 per share and revenue of $362.2410 million for the quarter. Investors may visit the the company's upcoming Q4 2025 earningresults page for the latest details on the call scheduled for Thursday, August 28, 2025 at 9:00 AM ET.

Phibro Animal Health Stock Up 2.9%

Shares of PAHC stock traded up $0.91 on Friday, hitting $32.46. The company's stock had a trading volume of 194,402 shares, compared to its average volume of 259,716. The company has a debt-to-equity ratio of 2.67, a current ratio of 2.91 and a quick ratio of 1.23. Phibro Animal Health has a fifty-two week low of $16.16 and a fifty-two week high of $32.95. The firm's fifty day moving average price is $28.14 and its 200-day moving average price is $24.04. The stock has a market capitalization of $1.32 billion, a price-to-earnings ratio of 41.62, a P/E/G ratio of 0.52 and a beta of 0.80.

Phibro Animal Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 24th. Shareholders of record on Wednesday, September 3rd will be given a dividend of $0.12 per share. The ex-dividend date of this dividend is Wednesday, September 3rd. This represents a $0.48 dividend on an annualized basis and a yield of 1.5%. Phibro Animal Health's payout ratio is currently 61.54%.

Analysts Set New Price Targets

A number of research firms have weighed in on PAHC. BNP Paribas Exane raised shares of Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 target price for the company in a research report on Monday, June 16th. Morgan Stanley set a $26.00 target price on shares of Phibro Animal Health and gave the stock an "equal weight" rating in a research report on Wednesday, June 25th. JPMorgan Chase & Co. raised shares of Phibro Animal Health from a "neutral" rating to an "overweight" rating and boosted their target price for the stock from $25.00 to $35.00 in a research report on Monday, July 7th. BNP Paribas raised shares of Phibro Animal Health to a "hold" rating in a research report on Monday, June 16th. Finally, Wall Street Zen raised shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. One research analyst has rated the stock with a Buy rating, three have issued a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Reduce" and a consensus target price of $24.40.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. State of Wyoming raised its position in shares of Phibro Animal Health by 148.8% during the second quarter. State of Wyoming now owns 6,608 shares of the company's stock valued at $169,000 after buying an additional 3,952 shares during the last quarter. Tower Research Capital LLC TRC increased its stake in Phibro Animal Health by 768.2% in the second quarter. Tower Research Capital LLC TRC now owns 4,610 shares of the company's stock valued at $118,000 after acquiring an additional 4,079 shares during the period. State of Tennessee Department of Treasury increased its stake in Phibro Animal Health by 18.6% in the second quarter. State of Tennessee Department of Treasury now owns 26,743 shares of the company's stock valued at $683,000 after acquiring an additional 4,200 shares during the period. Oxford Asset Management LLP bought a new stake in Phibro Animal Health in the second quarter valued at about $485,000. Finally, Lazard Asset Management LLC increased its stake in Phibro Animal Health by 3,392.3% in the second quarter. Lazard Asset Management LLC now owns 92,441 shares of the company's stock valued at $2,360,000 after acquiring an additional 89,794 shares during the period. Institutional investors and hedge funds own 99.34% of the company's stock.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.